Rogers DF - Search Results

1

Airway goblet cell hyperplasia in asthma: hypersecretory and anti-inflammatory?

Rogers DF. Rogers DF. Clin Exp Allergy. 2002 Aug;32(8):1124-7. doi: 10.1046/j.1365-2745.2002.01474.x. Clin Exp Allergy. 2002. PMID: 12190646 Review. No abstract available.

2

The airway goblet cell.

Rogers DF. Rogers DF. Int J Biochem Cell Biol. 2003 Jan;35(1):1-6. doi: 10.1016/s1357-2725(02)00083-3. Int J Biochem Cell Biol. 2003. PMID: 12467641 Review.

3

Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy.

Lai HY, Rogers DF. Lai HY, et al. Among authors: rogers df. Curr Opin Allergy Clin Immunol. 2010 Feb;10(1):67-76. doi: 10.1097/ACI.0b013e328334643a. Curr Opin Allergy Clin Immunol. 2010. PMID: 19907312 Review.

4

Motor control of airway goblet cells and glands.

Rogers DF. Rogers DF. Respir Physiol. 2001 Mar;125(1-2):129-44. doi: 10.1016/s0034-5687(00)00209-7. Respir Physiol. 2001. PMID: 11240157 Review.

5

Ovalbumin aerosol challenge in actively sensitized guinea pigs: relationship between airway microvascular leakage and airflow obstruction.

Hui KP, Lötvall J, Rogers DF, Barnes PJ, Chung FK. Hui KP, et al. Among authors: rogers df. Allergy. 1992 Oct;47(5):527-31. doi: 10.1111/j.1398-9995.1992.tb00677.x. Allergy. 1992. PMID: 1485657

6

Mucoactive agents for airway mucus hypersecretory diseases.

Rogers DF. Rogers DF. Respir Care. 2007 Sep;52(9):1176-93; discussion 1193-7. Respir Care. 2007. PMID: 17716385 Free article. Review.

7

New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.

Lai H, Rogers DF. Lai H, et al. Among authors: rogers df. J Aerosol Med Pulm Drug Deliv. 2010 Aug;23(4):219-31. doi: 10.1089/jamp.2009.0802. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 20695774 Review.

8

Airway goblet cells: responsive and adaptable front-line defenders.

Rogers DF. Rogers DF. Eur Respir J. 1994 Sep;7(9):1690-706. Eur Respir J. 1994. PMID: 7995400 Review.

9

Airway hypersecretion in allergic rhinitis and asthma: new pharmacotherapy.

Rogers DF. Rogers DF. Curr Allergy Asthma Rep. 2003 May;3(3):238-48. doi: 10.1007/s11882-003-0046-1. Curr Allergy Asthma Rep. 2003. PMID: 12662474 Review.

10

Airway mucus hypersecretion in asthma: an undervalued pathology?

Rogers DF. Rogers DF. Curr Opin Pharmacol. 2004 Jun;4(3):241-50. doi: 10.1016/j.coph.2004.01.011. Curr Opin Pharmacol. 2004. PMID: 15140415 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results